Abstract:Key PointsQuestionWhat are the prevalence rates of and odds for depression and anxiety in adults with hidradenitis suppurativa? FindingsThis systematic review and meta-analysis of 10 studies comprising 40307 participants with hidradenitis suppurativa found a prevalence of depression of 16.9% and a prevalence of anxiety of 4.9%. The odds ratio for depression among people with hidradenitis suppurativa was 1.84. MeaningDepression and anxiety are common comorbidities in people with hidradenitis suppurativa; efforts toward recognition, prevention, and management of those psychiatric comorbidities are warranted. This systematic review and meta-analysis evaluates 10 observational studies to assess the prevalence of depression and anxiety in patients with hidradenitis suppurativa and the odds of these psychiatric disorders in this population. ImportancePrevious studies suggest that depression and anxiety are common in patients with hidradenitis suppurativa (HS), more so than other dermatological conditions. Yet, to the authors' knowledge, no previous systematic review or meta-analysis has estimated the prevalence or odds ratio (OR) for those psychiatric comorbidities in this population. ObjectiveTo assess the prevalence and odds for depression and anxiety in patients with HS. Data SourcesFrom July 25 to September 30, 2018, observational studies investigating the prevalence and odds for depression and anxiety in adults with HS were systematically searched without language restriction from the inception of each database to July 25, 2018, in PubMed/MEDLINE, Embase, and PsycINFO databases. Searches used various configurations of the terms hidradenitis suppurativa; acne inversa; depressive disorder; depression; anxiety; anxiety disorders; phobia, social; suicide; and suicide, attempted. In addition, the reference lists of included references were screened manually. Study SelectionTwo investigators independently screened references that measured prevalence rates and odds for depressive and anxiety symptoms in patients with HS. Of 136 unique references, 10 ultimately met inclusion criteria. Data Extraction and SynthesisRelevant data were extracted from eligible references. Authors were contacted to provide further information when necessary. Methodological quality of included studies was assessed through a modified version of the Newcastle-Ottawa Scale. Random-effects models were used to synthesize available evidence. Main Outcomes and MeasuresPrevalence rates and ORs for depression and anxiety in adults with HS were the primary outcome measures. Heterogeneity across studies was assessed with the I-2 statistic. Sources of heterogeneity were explored through subgroup and meta-regression analyses. ResultsTen studies comprising 40307 participants with HS met inclusion criteria. The overall prevalence of depression was 16.9% (95% CI, 9.9%-27.2%). Heterogeneity was large. In the subgroup of studies that considered a clinical criteria-based diagnosis of depression, the prevalence of depression was 11.9% (95% CI, 4.9%-26.2%), compared with 26.8% (95% CI, 20.4%-34.5%) in studies that used a screening instrument. The methodological quality of included studies moderated those findings. The OR for depression in individuals with HS compared with individuals without HS was 1.84 (95% CI, 1.57-2.15). The prevalence of anxiety was 4.9% (95% CI, 1.7%-13.2%); there were insufficient data to determine an odds ratio for anxiety in persons with HS because 2 studies included a comparison group. Conclusions and RelevanceThis systematic review and meta-analysis indicates that depression and anxiety are common comorbid conditions in patients with HS. Results suggest that the development of strategies to recognize and treat those psychiatric comorbidities in patients with HS is warranted.

Health-Related Quality of Life, Depression and Anxiety Correlate with the Degree of Hirsutism

The Quality of Life and Psychosocial Impact on Female Pattern Hair Loss

Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic

BH08 Evaluating quality-of-life measures for alopecia: a comparative analysis of Dermatology Life Quality Index and Hospital Anxiety and Depression Scale correlations with disease severity

Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort

The Prevalence of Anxiety and Depression in Patients with or Without Hyperhidrosis (HH).

Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil

Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe

Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome

Prevalence of Non-Scarring Alopecia among Female Patients Complaining from Hirsutism

Depression and Anxiety in Adults with Hidradenitis Suppurativa

Association among depression, symptom experience, and quality of life in polycystic ovary syndrome

Acne in hirsute women

Psychological burden, anxiety, depression and quality of life in patients with hand eczema: A systematic review and meta‐analysis

The impact of the presence of hirsutism and hypertrichosis on the psychological state of women suffering from polycystic ovary syndrome and hyperandrogenism

Epidemiology of Hirsutism among Women of Reproductive Age in the Community: a Simplified Scoring System.

The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata

Quality of life in individuals with primary hyperhidrosis: a systematic review and meta-analysis

Associated Factors of Quality of Life in Adult Female Acne Coexisting with Hyperandrogenism and Polycystic Ovarian Syndrome using the Dermatology Life Quality Index

Hair removal and psychological well-being in transfeminine adults: associations with gender dysphoria and gender euphoria

Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.